VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
105 hedge funds and large institutions have $1.33B invested in Verona Pharma in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
105
Holders Change
+10
Holders Change %
+10.53%
% of All Funds
1.66%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.19%
New
21
Increased
30
Reduced
32
Closed
11
Calls
$3.32M
Puts
$9.42M
Net Calls
-$6.11M
Net Calls Change
-$7.49M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$53.8M |
| 2 |
PA
Perceptive Advisors
New York
|
+$35.2M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$26.8M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$21.4M |
| 5 |
Jennison Associates
New York
|
+$7.6M |
